Abbott Laboratories (NYSE: ABT)
Medical Devices · Abbott Park, IL, United States · Founded 1888
- Market capitalization: $200.0 billion
- Annual revenue: $44.33 billion
- Net income: $6.52 billion
- Employees: 114,000
- Sector: Healthcare
- Headquarters: Abbott Park, United States
- Founded: 1888
Source: Statvoo company profile for Abbott Laboratories. Browse all 500+ companies
Abbott is a diversified healthcare company operating across medical devices (FreeStyle Libre continuous glucose monitors), diagnostics (lab and rapid testing), nutrition (Similac, Ensure, Pedialyte), and established pharmaceuticals (sold primarily in emerging markets). The FreeStyle Libre has become the world's leading continuous glucose monitoring system with over 5 million users. Annual revenue exceeds $40 billion.
Medical Devices (led by FreeStyle Libre) is the growth engine. Diagnostics generates recurring revenue from test consumables. Nutrition sells branded products through retail and healthcare channels. Established Pharmaceuticals sells branded generics in emerging markets. The FreeStyle Libre's recurring sensor revenue (users replace sensors every 14 days) creates a powerful annuity stream.
Wallace Calvin Abbott founded the company in 1888 in Chicago. Abbott spun off AbbVie (pharmaceuticals) in 2013 to focus on medical devices, diagnostics, and nutrition. The $25 billion St. Jude Medical acquisition in 2017 strengthened the cardiac device portfolio. COVID rapid testing (BinaxNOW) generated billions in windfall revenue in 2021-2022. The company faced a major infant formula recall in 2022 that contributed to a national shortage.
| Market Capitalization | $200.0B |
| Annual Revenue | $44.33B |
| Net Income | $6.52B |
| Profit Margin | 15% |
| Revenue per Employee | $388860K |
| Stock Exchange | NYSE |
| Ticker Symbol | ABT |
Financial data is approximate and based on most recent annual filings.
Abbott's BinaxNOW COVID test became the most widely used rapid test in the US. The 2022 infant formula recall at Abbott's Sturgis, Michigan plant contributed to a nationwide formula shortage that became a political crisis. FreeStyle Libre has been approved for use without fingerstick calibration, making it the first truly hassle-free CGM.
FreeStyle Libre is a genuine growth franchise with a massive addressable market (Type 2 diabetes adoption is still early), and Abbott's diversification provides stability u2014 the formula recall was a black eye but not a lasting wound.
What is Abbott Laboratories's revenue?
Abbott Laboratories generates approximately $44.33 billion in annual revenue.
How many employees does Abbott Laboratories have?
Abbott Laboratories employs approximately 114,000 people worldwide.
What is Abbott Laboratories's market cap?
Abbott Laboratories (ABT) has a market capitalization of approximately $200.0 billion on the NYSE.
When was Abbott Laboratories founded?
Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, IL, United States.
Who is the CEO of Abbott Laboratories?
Robert Ford is the current CEO of Abbott Laboratories.
What is Abbott Laboratories's website?
Abbott Laboratories's official website is abbott.com.
| CEO | Robert Ford |
| Sector | Healthcare |
| Industry | Medical Devices |
| Founded | 1888 |
| HQ | Abbott Park, IL |
| Country | United States |
| Website | abbott.com |
See traffic, security, and technical data for Abbott Laboratories's website:
📊 abbott.com stats 📋 WHOIS 🌐 DNS 🔒 SSL